2017
DOI: 10.1016/j.prp.2017.02.003
|View full text |Cite
|
Sign up to set email alerts
|

Hypoxia reduces the E-cadherin expression and increases OSCC cell migration regardless of the E-cadherin methylation profile

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
9
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 19 publications
(11 citation statements)
references
References 41 publications
(52 reference statements)
2
9
0
Order By: Relevance
“…In OSCC cells, reduced E-cadherin was associated with HIF expression (136), which is congruent with the finding that lymph node metastasis and tumour recurrence in OSCC patients was associated with HIF-1a and VEGF (137,138). Similarly, the COX-2/PGE2 pathway, along with hypoxia, has been reported to contribute to OSCC metastases by increasing tumour cell migration and upregulation of intercellular adhesion molecule-1 (ICAM-1) (98,139,140).…”
Section: Mechanisms Linking Inflammation and Hypoxia In Progression Of Osccsupporting
confidence: 87%
“…In OSCC cells, reduced E-cadherin was associated with HIF expression (136), which is congruent with the finding that lymph node metastasis and tumour recurrence in OSCC patients was associated with HIF-1a and VEGF (137,138). Similarly, the COX-2/PGE2 pathway, along with hypoxia, has been reported to contribute to OSCC metastases by increasing tumour cell migration and upregulation of intercellular adhesion molecule-1 (ICAM-1) (98,139,140).…”
Section: Mechanisms Linking Inflammation and Hypoxia In Progression Of Osccsupporting
confidence: 87%
“…Total protein was extracted after BMSCs were treated with different concentrations of CoCl 2 for various time durations. Treatment duration was chosen based on previous studies (Domingos et al, ). Protein was also extracted 2 h after the medium with CoCl 2 was replaced with fresh medium.…”
Section: Methodsmentioning
confidence: 99%
“…Biochemical Genetics (2020) 58:213-244 with lower expression of E-cadherin protein in OSCC patients (Pannone et al 2014). In contrast, Domingos et al (2017) showed no differences in the methylation level of CDH1 promoter between groups of patients with potentially malignant oral lesions, OSCC, and healthy controls; moreover, in most samples the CDH1 gene promoter was unmethylated and in the OSCC group the level of methylation was not associated with clinicopathological features.…”
mentioning
confidence: 89%